Celltek Healthcare specializes in stem cell therapy and regenerative transplantation and treatments for a range of conditions, including sickle cell diseases
"Sickle cell disease is a genetic blood disorder that causes severe pain and complications. While there’s no universal cure yet, treatments like bone marrow transplants offer hope. At Celltek Healthcare , we’re here to provide care, support, and a path toward a brighter future."
"Sickle cell disease is a genetic blood disorder that causes severe pain and complications. While there’s no universal cure yet, treatments like bone marrow transplants offer hope. At Celltek Healthcare , we’re here to provide care, support, and a path toward a brighter future."
Celltek Healthcare Medical center is a specialised center for the cure of sickle cell disease and anemia
Follow us today
@GeneralHospital@WHO@health@w_sicklecell
Celltek Healthcare medical center specializes in stem cell therapy and regenerative transplantation and treatments for a range of conditions, including sickle cell disease, using stem cell transplantation.
The 1st person that Celtek did bone martow plant in December, 2017
Doing real good thereafter. Thank God for raising up a man to give succur to families, in the the person of Prof. Bazuaye @nigeria
Celltek healthcare medical center successful stem cells transplantation Donor on the right. Transplant done 5 yrs ago. Donor in good condition and patient cured of sickle cell disease. Thanks to our wonderful celltek https://t.co/gfBRCbSUX6 .@SickleCellMI@w_sicklecell
Celltek Healthcare Medical Center celebrates a landmark in multiple myeloma treatment with a successful stem cell transplant, marking a significant stride in combating this challenging disease. After a meticulous two-month journey, the center discharged the patient.
World Blood and Marrow transplant (WBMT) society council meeting 2024. Prof Bazuaye Godwin Nosakhare representing Africa as Secretary of Africa Blood and Marrow transplant society (AFBMT). In Glasgow Scotland on the 16th of April 2024